“…One application includes calculating the gland volume estimation which can be used for measuring drug-induced prostate volume changes ( Moore et al., 2017 ), for correlation with cancer volume ( Matsugasumi et al., 2015 ) and for detecting significant cancer ( Thompson et al., 2016 , Khalvati et al., 2016 ). Other applications also include for longitudinal analysis of patients undergoing active surveillance ( Stamatakis et al., 2013 ; Diaz et al., 2015 , Ouzzane et al., 2015 , Nguyen et al., 2015 , Lai et al., 2017 ), and as part of segmentation-driven multi-modal registration to support MRI-targeted transrectal-ultrasound (TRUS) guided biopsy and therapy ( Ouzzane et al., 2015 , Narayanan et al., 2009 , Onofrey et al., 2017 ). Relating the accuracy of these clinical measures to the accuracy of the output of different MRI segmentation networks (for example, those submitted to the PROMISE12 Challenge ( Fig.…”